Chad R. Baker’s Bristol-Myers Squibb BMY Stock Holding History

Chad R. Baker’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-23,200	Closed	-$1.47M	–	57
2018 Q1	$1.47M	Hold	23,200	–	–	0.58%	48
2017 Q4	$1.42M	Buy	23,200 +1,350	+6%	+$84.4K	0.56%	49
2017 Q3	$1.39M	Hold	21,850	–	–	0.55%	50
2017 Q2	$1.22M	Hold	21,850	–	–	0.48%	52
2017 Q1	$1.19M	Buy	21,850 +1,850	+9%	+$101K	0.48%	51
2016 Q4	$1.17M	Hold	20,000	–	–	0.52%	50
2016 Q3	$1.08M	Hold	20,000	–	–	0.46%	52
2016 Q2	$1.47M	Hold	20,000	–	–	0.66%	46
2016 Q1	$1.28M	Hold	20,000	–	–	0.58%	47
2015 Q4	$1.38M	Buy	+20,000	New	+$1.32M	0.61%	50

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chad R. Baker's BMY Position: Q2 2018 in Review

Chad R. Baker sold out of Bristol-Myers Squibb (BMY) in Q2 2018, closing a stake of 23,200 shares — an estimated $1.47M sold.

Chad R. Baker first reported a position in BMY in Q4 2015 and held it in 10 quarters. The position peaked at $1.47M in Q2 2016. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.

Chad R. Baker reported no remaining Bristol-Myers Squibb position as of Q2 2018 after selling out during the quarter.
Chad R. Baker sold 23,200 Bristol-Myers Squibb shares in Q2 2018, an estimated $1.47M.
Chad R. Baker first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 10 quarters.
Chad R. Baker's Bristol-Myers Squibb position peaked at $1.47M in Q2 2016.
1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.

Based on Chad R. Baker's 13F filing for Q2 2018, filed 13 Aug 2018.